Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 160,817,904
  • Shares Outstanding, K 5,666,593
  • Annual Sales, $ 58,496 M
  • Annual Income, $ 2,119 M
  • 60-Month Beta 0.63
  • Price/Sales 2.76
  • Price/Cash Flow 9.41
  • Price/Book 1.71
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 19.38% ( -1.20%)
  • Historical Volatility 26.93%
  • IV Percentile 3%
  • IV Rank 7.87%
  • IV High 33.73% on 10/27/23
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.33
  • Today's Volume 102,730
  • Volume Avg (30-Day) 223,553
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 3,091,426
  • Open Int (30-Day) 3,196,015

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.44
  • Number of Estimates 7
  • High Estimate 0.54
  • Low Estimate 0.32
  • Prior Year 0.67
  • Growth Rate Est. (year over year) -34.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.20 +14.46%
on 04/26/24
28.99 -0.50%
on 05/15/24
+2.93 (+11.33%)
since 04/15/24
3-Month
25.20 +14.46%
on 04/26/24
28.99 -0.50%
on 05/15/24
+1.33 (+4.85%)
since 02/15/24
52-Week
25.20 +14.46%
on 04/26/24
40.37 -28.54%
on 06/13/23
-8.32 (-22.38%)
since 05/15/23

Most Recent Stories

More News
3 No-Brainer Stocks to Buy With $500 Right Now

A modest amount of money can go a long way on Wall Street when it's put to work in game-changing companies.

COMP : 4.47 (+3.47%)
V : 281.21 (+1.25%)
OKTA : 99.75 (+1.90%)
PFE : 28.78 (+1.41%)
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential

These healthcare stocks offer completely different approaches to long-term investment gains.

PFE : 28.78 (+1.41%)
CRSP : 56.92 (+2.17%)
Is This a Setback for Moderna?

Moderna's shares slipped after the company announced the delay.

PFE : 28.78 (+1.41%)
GSK.LN : 1,809.240 (-0.04%)
MRNA : 128.66 (+0.26%)
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?

Moderate success regarding a new licensing deal with Sanofi could make the troubled vaccine stock a top performer.

PFE : 28.78 (+1.41%)
NVAX : 12.77 (-5.27%)
SNY : 48.86 (-1.29%)
How Viking Therapeutics Stock Could 30x

This mid-cap biopharma may one day be a titan of the industry.

LLY : 781.80 (+2.51%)
NVO : 134.42 (+1.13%)
VKTX : 77.17 (+6.44%)
PFE : 28.78 (+1.41%)
ViiV Healthcare Announces Health Canada Approval for APRETUDE (Cabotegravir tablets and extended release injectable suspension) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV

Approved for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV infection in at-risk adults and adolescents aged 12 years and older,...

PFE : 28.78 (+1.41%)
Forget Weight-Loss Drugs, Here's the Next Breakthrough Pharma Stock

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks...

PFE : 28.78 (+1.41%)
ABBV : 163.42 (+1.13%)
JNJ : 152.33 (+0.63%)
RHHBY : 31.4200 (+1.52%)
GMAB : 30.25 (+2.44%)
AZN : 76.93 (-0.14%)
DSNKY : 35.1350 (+1.31%)
MRK : 131.19 (+1.97%)
LLY : 781.80 (+2.51%)
NVO : 134.42 (+1.13%)
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock

Pfizer stock currently has a 5.9% dividend yield, making it an attractive target for income investors.

PFE : 28.78 (+1.41%)
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?

These stocks are both experts in their respective fields.

PFE : 28.78 (+1.41%)
NVO : 134.42 (+1.13%)
EXEL : 21.19 (+0.95%)
5 Standout Healthcare Dividend Stocks to Consider Now

Amid healthcare’s enduring importance and increasing demand for its products and services, here are five dividend-paying healthcare stocks to consider now.

JNJ : 152.33 (+0.63%)
MRK : 131.19 (+1.97%)
ABBV : 163.42 (+1.13%)
PFE : 28.78 (+1.41%)
MDT : 84.53 (+0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 29.13
2nd Resistance Point 28.91
1st Resistance Point 28.64
Last Price 28.78
1st Support Level 28.15
2nd Support Level 27.93
3rd Support Level 27.66

See More

52-Week High 40.37
Fibonacci 61.8% 34.57
Fibonacci 50% 32.78
Fibonacci 38.2% 30.99
Last Price 28.78
52-Week Low 25.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar